Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Octagon Capital Advisors LP | 1,115,000 9.300% | 1,115,000 (New Position) | Filing History |
| 2024-03-18 4:11 pm Purchase | 2024-03-08 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management, LP | 2,025,000 19.300% | 2,025,000 (New Position) | Filing History |
| 2024-02-28 4:38 pm Purchase | 2024-02-23 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Millennium Management LLC | 544,276 5.300% | 544,276 (New Position) | Filing History |
| 2024-02-14 4:45 pm Sale | 2023-12-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.500% | -10,182,288 (-96.75%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2022-10-25 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% | 10,524,401 (New Position) | Filing History |
| 2024-02-14 4:08 pm Sale | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm BioCapital Advisors LP | 0 0.000% | -399,658 (Position Closed) | Filing History |
| 2024-02-12 4:42 pm Purchase | 2024-02-02 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ADAGE CAPITAL PARTNERS GP L.L.C. | 796,392 7.700% | 796,392 (New Position) | Filing History |
| 2024-02-12 4:18 pm Purchase | 2024-02-02 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | RA CAPITAL MANAGEMENT L.P. | 430,182 4.100% | 430,182 (New Position) | Filing History |
| 2024-02-09 4:11 pm Purchase | 2024-01-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Integrated Core Strategies (US) LLC | 419,707 4.100% | 419,707 (New Position) | Filing History |
| 2024-02-05 4:47 pm Purchase | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Global Healthcare Master Fund LP | 1,475,000 14.270% | 1,475,000 (New Position) | Filing History |
| 2024-02-05 4:21 pm Purchase | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm BioCapital Advisors LP | 399,658 9.000% | 399,658 (New Position) | Filing History |
| 2024-01-29 4:40 pm Purchase | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Point72 Asset Management, L.P. | 388,676 8.800% | 388,676 (New Position) | Filing History |
| 2024-01-26 4:28 pm Purchase | 2024-01-26 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | TANG CAPITAL PARTNERS LP | 426,220 9.600% | 426,220 (New Position) | Filing History |
| 2022-08-24 1:59 pm Sale | 2022-08-23 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 206,489 4.950% | -160,016 (-43.66%) | Filing History |
| 2022-02-14 3:55 pm Sale | 2022-02-11 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 366,505 8.780% | -108,174 (-22.79%) | Filing History |